InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.290 0.02 (0.87%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$854 Change in substantial holding 4 Sep 2026 4:31PM $2.310 $2.290 fallen by 0.87%
$854 Change in substantial holding from CGF 4 Sep 2026 4:26PM $2.310 $2.290 fallen by 0.87%
$854 Notification of cessation of securities - IDX 28 Aug 2026 5:04PM $2.250 $2.290 risen by 1.78%
$854 Notification regarding unquoted securities - IDX 28 Aug 2026 4:54PM $2.250 $2.290 risen by 1.78%
$854 Notification of cessation of securities - IDX 28 Aug 2026 4:42PM $2.250 $2.290 risen by 1.78%
$854 Notification regarding unquoted securities - IDX 28 Aug 2026 11:28AM $2.260 $2.290 risen by 1.33%
$854 Change of Director's Interest Notice - Ingrid Player NED 28 Aug 2026 8:06AM $2.330 $2.290 fallen by 1.72%
$854 Change of Director's Interest Notice - Jason Martinez CEO 28 Aug 2026 8:05AM $2.330 $2.290 fallen by 1.72%
$854 Dividend/Distribution - IDX 25 Aug 2026 9:20AM $2.280 $2.290 risen by 0.44%
$854 FY26 Appendix 4G 25 Aug 2026 9:18AM $2.280 $2.290 risen by 0.44%
$854 FY26 Full Year Investor Presentation 25 Aug 2026 9:14AM $2.280 $2.290 risen by 0.44%
$854 FY26 Full Year Results Announcement 25 Aug 2026 9:13AM $2.280 $2.290 risen by 0.44%
$854 FY26 Annual Report 25 Aug 2026 9:13AM $2.280 $2.290 risen by 0.44%
$854 2026 Annual General Meeting Date 20 Aug 2026 3:07PM $2.225 $2.290 risen by 2.92%
$854 Change in substantial holding 13 Aug 2026 4:03PM $2.235 $2.290 risen by 2.46%
$854 Preliminary FY26 Results and Appointment of New CFO 10 Aug 2026 9:05AM $2.180 $2.290 risen by 5.05%
$854 Initial Director's Interest Notice - Jason Martinez 7 Aug 2026 8:58AM $2.230 $2.290 risen by 2.69%
$854 Final Director's Interest Notice - Dr Ian Kadish 7 Aug 2026 8:57AM $2.230 $2.290 risen by 2.69%
$854 Start for New Managing Director and Chief Executive Officer 6 Aug 2026 9:00AM $2.220 $2.290 risen by 3.15%
$854 Re-issued IDX FY26 Results Conference Call 23 Jul 2026 5:21PM $2.070 $2.290 risen by 10.63%
$854 IDX FY26 Results Conference Call 23 Jul 2026 11:49AM $2.080 $2.290 risen by 10.10%
$854 Change of Director's Interest Notice - Dr Ian Kadish 1 Jul 2026 4:22PM $2.010 $2.290 risen by 13.93%
$854 Notification regarding unquoted securities - IDX 1 Jul 2026 4:20PM $2.010 $2.290 risen by 13.93%
$854 Change of Director's Interest Notice - Toby Hall 25 Jun 2026 10:53AM $2.010 $2.290 risen by 13.93%
$854 Becoming a substantial holder 23 Jun 2026 5:00PM $1.965 $2.290 risen by 16.54%

1 - 25 of 782 results

Page 1 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.